Revive Therapeutics Announces Extension of Proposed Private Placement
Revive Therapeutics Announces Extension of Proposed Private Placement GlobeNewswire September 05, 2025 TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is extending is previously announced private […]